Poging GOUD - Vrij
Mid-size IT firms to remain ahead of larger rivals in Q2
Mint Kolkata
|October 08, 2025
Coforge is expected to top the charts on the back of strong deal wins in the travel vertical
India's mid-sized information technology (IT) services firms, those with annual revenues between $1 billion and $5 billion, are expected to outperform their larger peers for a third consecutive quarter, buoyed by strong deal wins and business captured from bigger rivals.
Companies, including LTIMindtree Ltd, Coforge Ltd, Mphasis Ltd, Persistent Systems Ltd and Hexaware Technologies Ltd, are likely to report a sequential revenue growth between 1.2% and 6.6% in the July-September period, according to at least six brokerages. Among these firms, Coforge may top the charts on the back of strong deal wins in travel space and quick ramp-up of previous wins. The company's $120 million annual deal with Texas-based travel technology firm Sabre, its largest to date, has helped sustain growth.
Ninth largest, Persistent, comes a close second and is expected to post a 4.2% sequential growth at best, with experts attributing this to increased business from banks and healthcare centres. In contrast, larger peers, including Tata Consultancy Services Ltd, Infosys Ltd, HCL Technologies Ltd, Wipro Ltd and Tech Mahindra Ltd, are expected to grow no more than 2.8%. Of these, the second-largest, Infosys, is expected to perform the best of the pack for the second straight quarter, thanks to deal ramp-ups and increased funding from banks.
Dit verhaal komt uit de October 08, 2025-editie van Mint Kolkata.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Kolkata
Mint Kolkata
When LLMs learn to take shortcuts, they become evil
Some helpful parenting tips: it is very easy to accidentally teach your children lessons you did not intend to pass on.
2 mins
November 28, 2025
Mint Kolkata
Investors expect AI use to soar. That's not happening
An uncertain outlook for interest rates. Businesses may be holding off on investment until the fog clears. In addition, history suggests that technology tends to spread in fits and starts. Consider use of the computer within American households, where the speed of adoption slowed in the late 1980s. This was a mere blip before the 1990s, when they invaded American homes.
2 mins
November 28, 2025
Mint Kolkata
Would you like to be interviewed by an AI bot instead?
don't think I want to be interviewed by a human again,\" said a 58-year-old chartered accountant who recently had an interview with a multinational company.
3 mins
November 28, 2025
Mint Kolkata
Can I claim TDS refund despite missing return filing deadline?
I am an NRI living in Dubai and have investments in Indian listed stocks. One of the companies I invested in, did a buyback in March, on which Tax Deducted at Source (TDS) was deducted. At that time, I was advised by a friend that I could claim a refund of TDS at the time of filing my tax return due to the benefits of the Double Taxation Avoidance Agreement (DTAA).
2 mins
November 28, 2025
Mint Kolkata
Tech startups on M&A route to boost scale, market share
M&As were earlier used to enter new markets or geographies, but that strategy has evolved
2 mins
November 28, 2025
Mint Kolkata
Doing India’s needy a good turn: Everyone is welcome to pitch in
What may seem weakly linked with positive outcomes on the ground could work wonders over time
3 mins
November 28, 2025
Mint Kolkata
Refiners, SCI tap Korean giants for local shipyard
Indian Oil, Bharat Petroleum and Hindustan Petroleum are part of the discussions
2 mins
November 28, 2025
Mint Kolkata
It's a multi-horse Street race now as Smids muscle in
For years, India’s stock market ran on the shoulders of a few giants. Not anymore.
1 mins
November 28, 2025
Mint Kolkata
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Kolkata
What if China weaponizes its dominance of pharma inputs?
Overdependence on China for drug-making should worry the US
3 mins
November 28, 2025
Listen
Translate
Change font size

